Drivers found in squamous cell carcinoma (SCC, accounting for 35% of NSCLC patients) are much less frequently actionable and include TP53, PIK3CA, CDKN2A, SOX2, and CCND1 alterations (4). The gene discussed is TP53; the disease is non-small cell lung carcinoma.